Priscilla Brebi

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
The Role of MNX1-AS1 in Ovarian Cancer Resistance and Tumor Progression via RNA-RNA Interactions.

|Feb 13, 2025
Patient-Derived Organoid Models for NKT Cell-Based Cancer Immunotherapy.

Pablo A Palacios, Iván Flores, Lucas Cereceda

|Jan 18, 2025
Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival.

Bárbara Mora-Lagos, María Elena Reyes, Lorena Lobos-Gonzalez

|Jul 20, 2021
Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms.

Yuselin Mora, María Elena Reyes, Louise Zanella

|Jan 29, 2020
Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.

Barbara Mora-Lagos, Irene Cartas-Espinel, Ismael Riquelme

|Dec 20, 2018
Loss of ZNF516 protein expression is related with HR-HPV infection and cervical preneoplastic lesions.

Carmen Ili, Jaime Lopez, Kurt Buchegger

Pageof 1

Frequent Collaborators

2 joint publications

Carmen Ili

1 joint publications

Barbara Mora-Lagos

1 joint publications

Irene Cartas-Espinel

1 joint publications

Yuselin Mora